LT5255B - Citalopramas, skirtas padidėjusio kraujo spaudimo gydymui - Google Patents

Citalopramas, skirtas padidėjusio kraujo spaudimo gydymui Download PDF

Info

Publication number
LT5255B
LT5255B LT2004049A LT2004049A LT5255B LT 5255 B LT5255 B LT 5255B LT 2004049 A LT2004049 A LT 2004049A LT 2004049 A LT2004049 A LT 2004049A LT 5255 B LT5255 B LT 5255B
Authority
LT
Lithuania
Prior art keywords
citalopram
treatment
hypertension
blood pressure
pharmaceutically acceptable
Prior art date
Application number
LT2004049A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2004049A (en
Inventor
Pal. S. Gabor
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of LT2004049A publication Critical patent/LT2004049A/xx
Publication of LT5255B publication Critical patent/LT5255B/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LT2004049A 2002-03-14 2004-05-12 Citalopramas, skirtas padidėjusio kraujo spaudimo gydymui LT5255B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (sh) 2002-03-14 2002-03-14

Publications (2)

Publication Number Publication Date
LT2004049A LT2004049A (en) 2005-03-25
LT5255B true LT5255B (lt) 2005-08-25

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2004049A LT5255B (lt) 2002-03-14 2004-05-12 Citalopramas, skirtas padidėjusio kraujo spaudimo gydymui

Country Status (35)

Country Link
US (1) US7141604B2 (sh)
EP (1) EP1490049B1 (sh)
JP (1) JP2005519945A (sh)
KR (1) KR100718368B1 (sh)
CN (1) CN1259912C (sh)
AT (1) ATE324887T1 (sh)
AU (1) AU2003211195B2 (sh)
BG (1) BG108904A (sh)
BR (1) BR0303384A (sh)
CA (1) CA2459834A1 (sh)
CY (1) CY1106129T1 (sh)
CZ (1) CZ2004661A3 (sh)
DE (1) DE60305018T2 (sh)
DK (1) DK1490049T3 (sh)
EA (1) EA008350B1 (sh)
EE (1) EE200400069A (sh)
ES (2) ES2238939B2 (sh)
HK (1) HK1075390A1 (sh)
HR (1) HRP20040165B1 (sh)
HU (1) HU0200980D0 (sh)
IL (2) IL160486A0 (sh)
IS (1) IS2392B (sh)
LT (1) LT5255B (sh)
LV (1) LV13281B (sh)
MX (1) MXPA04008919A (sh)
NO (1) NO20034998D0 (sh)
PL (1) PL368902A1 (sh)
PT (1) PT1490049E (sh)
SI (1) SI1490049T1 (sh)
SK (1) SK2222004A3 (sh)
TR (1) TR200401036T1 (sh)
UA (1) UA77506C2 (sh)
WO (1) WO2003075914A1 (sh)
YU (1) YU91203A (sh)
ZA (1) ZA200408056B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004283047B2 (en) * 2003-10-10 2009-09-17 Abbott Laboratories Gmbh Pharmaceutical composition comprising a selective I1 imidazoline receptor agonist and an angiotensin II receptor blocker
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657103A1 (de) 1975-12-16 1977-06-23 Du Pont Canada Verfahren zur behandlung von zerkleinertem hafer
WO1998019513A2 (en) 1997-07-08 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
WO1998019512A2 (en) 1997-11-11 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657103A1 (de) 1975-12-16 1977-06-23 Du Pont Canada Verfahren zur behandlung von zerkleinertem hafer
WO1998019513A2 (en) 1997-07-08 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
WO1998019512A2 (en) 1997-11-11 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram

Also Published As

Publication number Publication date
JP2005519945A (ja) 2005-07-07
NO20034998D0 (no) 2003-11-10
ATE324887T1 (de) 2006-06-15
PL368902A1 (en) 2005-04-04
ES2263009T3 (es) 2006-12-01
EP1490049B1 (en) 2006-05-03
EP1490049A1 (en) 2004-12-29
IL160486A (en) 2008-06-05
WO2003075914A1 (en) 2003-09-18
DK1490049T3 (da) 2006-08-21
SK2222004A3 (en) 2004-08-03
IS7418A (is) 2004-08-20
IS2392B (is) 2008-08-15
LT2004049A (en) 2005-03-25
AU2003211195A1 (en) 2003-09-22
AU2003211195B2 (en) 2007-10-18
HU0200980D0 (sh) 2002-05-29
CY1106129T1 (el) 2011-06-08
MXPA04008919A (es) 2004-11-26
KR20040090949A (ko) 2004-10-27
HK1075390A1 (en) 2005-12-16
BG108904A (en) 2006-04-28
DE60305018T2 (de) 2006-11-30
UA77506C2 (en) 2006-12-15
DE60305018D1 (de) 2006-06-08
CN1568183A (zh) 2005-01-19
EA200401147A1 (ru) 2005-02-24
ES2238939A1 (es) 2005-09-01
YU91203A (sh) 2006-08-17
EA008350B1 (ru) 2007-04-27
US7141604B2 (en) 2006-11-28
BR0303384A (pt) 2004-03-30
HRP20040165B1 (en) 2007-08-31
CA2459834A1 (en) 2003-09-18
CZ2004661A3 (cs) 2004-10-13
PT1490049E (pt) 2006-08-31
LV13281B (en) 2005-09-20
SI1490049T1 (sl) 2006-10-31
ES2238939B2 (es) 2006-04-16
ZA200408056B (en) 2005-10-10
IL160486A0 (en) 2004-07-25
US20050065209A1 (en) 2005-03-24
AU2003211195A2 (en) 2003-09-22
EE200400069A (et) 2004-08-16
KR100718368B1 (ko) 2007-05-14
CN1259912C (zh) 2006-06-21
HRP20040165A2 (en) 2004-10-31
TR200401036T1 (tr) 2005-10-21

Similar Documents

Publication Publication Date Title
EP3272343B1 (en) Tapentadol for preventing and treating depression and anxiety
MX2008000249A (es) Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos.
EP3043799A1 (en) An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease
JP2008519810A (ja) 顔面紅潮の治療のためのsミルタザピン
LT5255B (lt) Citalopramas, skirtas padidėjusio kraujo spaudimo gydymui
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
EP2665474A1 (en) Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
JP5436419B2 (ja) 精神障害の治療方法および治療用医薬組成物
RU2321398C2 (ru) Способ лечения
ZA200207111B (en) Use of deramciclane for the treatment of anxiety and depression.
OA16802A (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation.

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20090313